Lab Automation Market to Register Substantial Expansion In Coming Years

4Dec - by mnm - 0 - In Healthcare Technology

Lab automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. The degree of automation that any lab requires depends on its workflow. While an academic research lab may prefer to use only some instruments in order to increase productivity and reduce the time spent on a tedious task, a drug discovery unit in a pharmaceutical company will perhaps need to automate all of its research phases.

What the Market Looks Like?

Predicted to grow at a CAGR of 5.1% during the forecast period, the global Lab Automation Market is estimated to reach USD 5.20 Billion by the end of 2022. In 2017, North America is projected to account for the largest share of the global lab automation market.

Based on equipment and software, the market is segmented into automated workstations, off-the-shelf workcells, robotic systems, automated storage and retrieval system, software, and other equipment. In 2017, the automated workstation segment is expected to account for the largest share of the lab automation market. The high demand for automation in liquid handling is the key factor driving market growth in this segment. Automated workstations offer advantages such as enhanced accuracy, and reduced time and cost.

Based on end user, the lab automation market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and research and academic institute. In 2017, the biotechnology & pharmaceutical companies segment is expected to account for the largest share of the lab automation market. Factors such as increasing product intricacy, pricing pressure, high cost incurred by errors, and need for consistency in quality are driving biotechnology and pharmaceutical companies to adopt automation and accelerate the drug discovery process.

Please provide your specific interest in this report so as to help you better, Download PDF Brochure @

What Drives the Market?

The growth of the global market for Lab Automation is primarily influenced by the following factors:

  • Benefits of Lab Automation
  • Rising Geriatric Population
  • Miniaturization of Processes
  • Progressing Markets of Drug Discovery and Diagnostics
  • Government Funding for Biotech and Drug Discovery Research

Factors such as process miniaturization, high demand for lab automation equipment in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and large workforce demand and supply gap are likely to drive the growth of this market. In addition, lab automation offers enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents.

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request for Sample Pages :

Geographical growth scenario of Lab Automation Market

Geographically, the Lab Automation market has been studied for North America, Europe, Asia Pacific, and RoW. In 2017, North America is projected to account for the largest share of the global lab automation market. The demand for lab automation in North America is driven by the increasing number of investments in research and innovation by the government, large presence of pharmaceutical R&D labs in this region, and lab automation adoption by hospitals and clinical diagnostic labs due to increasing volume of tests.

Leading market players and strategies adopted

The prominent players in the Lab Automation market include Tecan Group (Switzerland), PerkinElmer (US), Danaher (Beckman Coulter & Molecular Devices) (US), Thermo Fisher (US), Agilent Technologies (US), Hamilton Robotics (US), Abbot Diagnostics (US), Eppendorf (Germany), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany).

Please share your specific interest to serve you better, Request for Bundle Reports @

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Visit Our Website: